Influenza A (H1N1) 2009: A perspective at the end of the pandemic;Grip A (H1N1) 2009: Perspectiva final de la pandèmia

Pediatria Catalana

Volumn 70, Issue 4, 2010, Pages 151-157

  Campins Martí, Magda ^a   González Baulies, Roser ^a   Vaqué Rafart, Josep ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

Influenza A (H1N1); Mortality; Pandemic; Vaccination

Indexed keywords

INFLUENZA VACCINE;

HEALTH CARE COST; HUMAN; INFLUENZA A (H1N1); INFLUENZA VACCINATION; INFLUENZA VIRUS A H1N1; MORBIDITY; MORTALITY; NONHUMAN; PANDEMIC INFLUENZA; REVIEW;

EID: 79951996256     PISSN: 11358831     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (41)

1. Kawaoka Y, Krauss S, Webster RG. Avian-to-human transmission of the PB1 gene of influenza A viruses in the 1957 and 1968 pandemics. J Virol 1989; 63: 4.603-4.608.
2. Potter CW. A history of influenza. J Appl Microbiol 2001; 91: 572-579.
3. Belshe RB. The origins of pandemic influenza: lessons from 1918 virus. N Engl J Med 2005; 353: 2.209-2.211.
4. Garten RJ, Davis CT, Russell CA, Shu B, Lindstrom S, Balish A, et al. Antigenic and genetic characteristics of swine-origin 2009 A (H1N1) influenza viruses circulating in humans. Science 2009; 325: 197-201.
5. WHO. World now at the start of 2009 influenza pandemic. Statement to the press by WHO Director-General Dr Margaret Chan. 11 June 2009. Accessible a la xarxa [data de consulta: 24-09-20101. Disponible a: http: //www.who.int/ mediacentre/news/statements/2009/h1n1-pandemic-phase6-20090611/en/index.html
6. Centers for Disease Control and Prevention. Outbreak of swine-origin Influenza A (H1N1) virus infection-Mexico, March-April 2009. MMWR 2009; 58: 467-470.
7. WHO. Pandemic (H1N1) 2009. Update 107. Accessible a la xarxa [data de consulta: 8-07-2010]. Disponible a: http: //www.who.int/csr/don/2010-07-02/en/ index.html
8. CDC. CDC Estimates of 2009 H1N1 Influenza Cases, Hospitalizations and Deaths in the United States, April 2009 - March 13, 2010. Accessible a la xarxa [data de consulta: 8-07-2010]. Disponible a: http: //www.cdc.gov/h1n1flu/ estimates/April-March-13.htm#Table Cumulative
9. Jain S, Kamimoto L, Bramley AM, Schmitz AM, Benoit SR, Louie J, et al. Hospitalized Patients with 2009 H1N1 Influenza in the United States, April-June 2009. N Engl J Med 2009; 361: 1.935-1.944.
10. Ministerio de Sanidad y Política Social. Casos humanos de gripe por virus pandémico (H1N1) 2009. Análisis descriptivo de los casos fallecidos en España. Accessible a la xarxa [data de consulta: 25-05-2010]. Disponible a: http: //www.msc.es/profesionales/saludPublica/gripeA/ docs/informacionFallecidosH1N1-091201.pdf
11. Departement de Salut. Generalitat de Catalunya. Pla d'actuació a Catalunya enfront d'una infecció pel virus pandèmic (H1N1) 2009. 4 de febrer de 2010. Accessible a la xarxa [data de consulta: 25-05-2010]. Disponible a: http: //www.gencat.cat/salut/depsalut/html/ca/dir3341/gr27042009. pdf
12. Comitè Assessor de la Grip A (H1N1). Balanç provisional de la primera onada de la pandèmia de grip A (H1N1). Departement de Salut, Generalitat de Catalunya. Reunió 12 de febrer de 2010.
13. CDC. Swine-origin influenza A(H1N1) virus infections in a school-New York City, April 2009. MMWR 2009; 58: 470-472.
14. Novel swine-origin influenza A (N1N1) Virus Investigation Team. Emergence of a novel swine-origin influenza A (N1N1) virus in humans. N Engl J Med 2009; 360: 2.605-2.615.
15. U.S. Department of Health and Human Services. Assessment of the 2009 Influenza A (H1N1) pandemic on selected countries in the southern hemisphere: Argentina, Australia, Chile, New Zealand and Uruguay. Accessible a la xarxa [data de consulta: 25-05-20101. Disponible a: http: //www.flu.gov/professional/ global/southhemisphere.html.
16. Vaqué J, Gil J, Brotons M. Principales características de la pandemia por el nuevo virus influenza A (H1N1). Med Clin (Barc) 2009; 133: 513-521.
17. Ministerio de Sanidad y Política Social (España). Informe semanal de situación nacional e internacional. Fecha: 17.12.09. Accessible a la xarxa [data de consulta: 19-12-2009]. Disponible a: http: //www.msps.es/profesionales/saludPublica/gripeA/docs/20091217- InformeSituacionNacionalInternacional-SEM49.pdf
18. Departement de Salut. Pla d'informació de les infeccions respiratòries agudes a Catalunya. Temporada gripal 2009-2010. Full informatiu núm. 10 (17.12.09). Accessible a la xarxa [data de consulta: 19-12-2009]. Disponible a: http: //www.gencat.cat/salut/depsalut/html/ca/ dir2097/spfi.pdf
19. Health Protection Agency. Pandemic (H1N1) 2009 in England: an overview of initial epidemiological findings and implications for the second wave. V3 24 de novembre de 2009. Accessible a la xarxa [data de consulta: 18-12-20091. Disponible a: http: //www.hpa.org.uk/web/HPAwebFile/HPAweb-C/1258560552857.
20. CDC estimates of 2009 H1N1 influenza cases, hospitalizations and deaths in the United States, April-November 14, 2009. Accessible a la xarxa [data de consulta: 17-12-2009]. Disponible a: http: //www.cdc.gov/h1n1flu/estimates-2009- h1n1.htm
21. Vaqué J. Epidemiología de la gripe A(H1N1) en el mundo y en España. Arch Bronconeumol 2010; 46(Supl 2): 3-12.
22. WHO. Human infection with new influenza A (H1N1) virus: clinical observations from Mexico and other affected countries, May 2009. WER. 2009; 84: 185-190.
23. México. Situación actual de la epidemia, 16 de diciembre de 2009. Estados Unidos Mexicanos, 2009. Accessible a la xarxa [data de consulta: 19-12-2009]. Disponible a: http: //portal.salud.gob.mx/contenidos/sala-prensa/ sala-prensa-prensa/sala-prensa-boletines.html
24. CDC. Flu-related hospitalizations and deaths in the United States from April 2009-January 30, 2010. Accessible a la xarxa [data de consulta: 24-09-20101. Disponible a: http: //www.cdc.gov/h1n1flu/hosp-deaths-ahdra.htm
25. Garske T, Legrand J, Donnelly CA, Ward H, Cauchemez S, Fraser C, Ghani AC. Assessing the severity of the novel influenza A/H1N1 pandemic. BMJ 2009; 339: B2840.
26. CDC. Surveillance for pediatric deaths associated with 2009 pandemic influenza A (H1N1) virus infection: United States, April-August 2009. MMWR 2009; 58: 941-947.
27. Libster R, Bugna J, Coviello S, Hijano DR, Dunaiewsky M, Reynoso N, et al. Pediatric hospitalizations associated with 2009 pandemic influenza A (H1N1) in Argentina. N Engl J Med 2010; 362: 45-55.
28. O'Riordan S, Barton M, Yau Y, Read SE, Allen U, Tran D. Risk factors and outcomes among children admitted to hospital with pandemic H1N1 influenza. CMAJ 2009. doi: 10.1503/cmaj.091724.
29. R. González, R. Cebrián, T. Tórtola, V. Balasso, M. Sancosmed, J.A. Rodrigo, et al. Risk factors and outcomes among children attended to in a tertiary hospital with pandemic H1N1 influenza [pòster]. 28è Congrés de l'European Society of Pediatric Infectious Diseases. Niça, 2010.
30. Comission Staff Working Document. Regulatory process for the authorization of antiviral medicines and vaccines in the protection against pandemic influenza (H1N1) 2009. Commission of the European Communities; 2009.
31. Bayas JM, Campins M. Estado actual de las vacunas trente a la gripe pandémica. Enf Infec Microbiol Clin 2007; 25: 78-85.
32. Petrovsky N, Aguilar JC. Vaccine adjuvants: current state and future trends. Immunol Cell Biol 2004; 82: 488-496. (Pubitemid 39421058)
33. Pellegrini M, Nicolay U, Lindert K, Groth N, Cioppa GD. MF59-adjuvanted versus nonadjuvanted influenza vaccines: Integrated analysis from a large safety database. Vaccine 2009; 27: 6.959-6.965.
34. European Medicines Agency. Pandemic influenza A (H1N1)v vaccines authorized via the core dossier procedure. Explanatory note on scientific considerations regarding the licensing of pandemic A (H1N1)v vaccines. 24 September 2009. Accessible a la xarxa [data de consulta: 26-05-2010]. Disponible a: http: //www.emea.europa.eu/pdfs/human/pandemicinfluenza/60825909en.pdf
35. Greenberg ME, Lai MH, Hartel GF, Wichems CH, Gittleson C, Bennet J, et al. Response to a monovalent 2009 influenza A (H1N1) vaccine. N Engl J Med 2009; 361: 2.405-2.413.
36. Clark TW, Pareek M, Hoschler K, Dillon H, Nicholson KG, et al. Trial of Influenza A (H1N1) 2009 Monovalent MF59-Adjuvanted Vaccine. N Engl J Med 2009; 361: 2.424-2.435.
37. Pascua PNQ, Song M-S, Lee JH, Park KJ, Kwon H-i, et al. Evaluation of the Efficacy and Cross-Protectivity of Recent Human and Swine Vaccines against the Pandemic (H1N1) 2009 Virus Infection. PLoS ONE 4(12): e8431. doi: 10.1371/journal.pone.0008431.
38. Johansen K, Nicoll A, Ciancio BC, Kramarz P. Pandemic influenza A (H1N1) 2009 vaccines in the European Union. Eurosurveillance 2009; 14: 19.361.
39. WHO. Safety pandemic vaccines. 2009. Accessible a la xarxa [data de consulta: 24-09-20101. Disponible a: http: //www.who.int/csr/disease/swineflu/ notes/briefing-20091119/en/index.html
40. EMEA. Pandemic pharmacovigilance weekly update. 2010. Accessible a la xarxa [data de consulta: 20-03-20101. Disponible a: http: //www.ema.europa.eu/ influenza/newsroom/newsroom.html
41. CDC. VAERS. Summary of 2009 monovalent H1N1 influenza vaccine data. Accessible a la xarxa [data de consulta: 20-03-2010]. Disponible a: http: //vaers.hhs.gov/resources/h1n1update#top